Annual EBIT
-$37.81 M
+$35.71 M+48.58%
31 December 2023
Summary:
Seelos Therapeutics annual earnings before interest & taxes is currently -$37.81 million, with the most recent change of +$35.71 million (+48.58%) on 31 December 2023. During the last 3 years, it has fallen by -$18.87 million (-99.65%). SEEL annual EBIT is now -762.22% below its all-time high of $6.05 million.SEEL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$1.73 M
+$4.37 M+165.62%
30 June 2024
Summary:
Seelos Therapeutics quarterly earnings before interest & taxes is currently $1.73 million, with the most recent change of +$4.37 million (+165.62%) on 30 June 2024. Over the past year, it has dropped by -$8.81 million (-83.56%). SEEL quarterly EBIT is now -83.56% below its all-time high of $10.54 million, reached on 30 September 2023.SEEL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
$4.20 M
+$31.22 M+115.53%
30 June 2024
Summary:
Seelos Therapeutics TTM earnings before interest & taxes is currently $4.20 million, with the most recent change of +$31.22 million (+115.53%) on 30 June 2024. Over the past year, it has increased by +$55.23 million (+108.23%). SEEL TTM EBIT is now at all-time high.SEEL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SEEL EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +48.6% | -83.6% | +108.2% |
| 3 y3 years | -99.7% | +116.0% | +109.7% |
| 5 y5 years | -310.1% | +153.8% | +108.8% |
SEEL EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -99.7% | +48.6% | -83.6% | +105.9% | at high | +105.1% |
| 5 y | 5 years | -310.1% | +48.6% | -83.6% | +105.9% | at high | +105.1% |
| alltime | all time | -762.2% | +48.6% | -83.6% | +104.9% | at high | +105.1% |
Seelos Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $1.73 M(-165.6%) | $4.20 M(-115.5%) |
| Mar 2024 | - | -$2.64 M(-51.4%) | -$27.02 M(-28.5%) |
| Dec 2023 | -$37.81 M(-48.6%) | -$5.43 M(-151.6%) | -$37.81 M(-25.9%) |
| Sept 2023 | - | $10.54 M(-135.7%) | -$51.03 M(-37.1%) |
| June 2023 | - | -$29.49 M(+119.7%) | -$81.17 M(+11.3%) |
| Mar 2023 | - | -$13.42 M(-28.0%) | -$72.95 M(-0.8%) |
| Dec 2022 | -$73.52 M(+14.1%) | -$18.66 M(-4.8%) | -$73.52 M(-10.5%) |
| Sept 2022 | - | -$19.60 M(-7.8%) | -$82.12 M(+12.0%) |
| June 2022 | - | -$21.27 M(+52.0%) | -$73.31 M(+21.5%) |
| Mar 2022 | - | -$13.99 M(-48.7%) | -$60.32 M(-6.4%) |
| Dec 2021 | -$64.45 M(+240.3%) | -$27.25 M(+152.5%) | -$64.45 M(+48.2%) |
| Sept 2021 | - | -$10.79 M(+30.5%) | -$43.49 M(+18.2%) |
| June 2021 | - | -$8.28 M(-54.3%) | -$36.78 M(+14.1%) |
| Mar 2021 | - | -$18.13 M(+187.8%) | -$32.23 M(+70.2%) |
| Dec 2020 | -$18.94 M(-63.0%) | -$6.30 M(+54.2%) | -$18.94 M(-18.7%) |
| Sept 2020 | - | -$4.08 M(+9.6%) | -$23.30 M(+3.9%) |
| June 2020 | - | -$3.73 M(-22.8%) | -$22.43 M(+9.1%) |
| Mar 2020 | - | -$4.83 M(-54.7%) | -$20.56 M(-59.9%) |
| Dec 2019 | -$51.23 M(+455.7%) | -$10.66 M(+231.0%) | -$51.23 M(+7.5%) |
| Sept 2019 | - | -$3.22 M(+73.9%) | -$47.64 M(+4.8%) |
| June 2019 | - | -$1.85 M(-94.8%) | -$45.45 M(-0.8%) |
| Mar 2019 | - | -$35.50 M(+401.6%) | -$45.84 M(+263.4%) |
| Dec 2018 | -$9.22 M(-21.0%) | -$7.08 M(+587.0%) | -$12.61 M(+54.9%) |
| Sept 2018 | - | -$1.03 M(-54.0%) | -$8.14 M(-26.8%) |
| June 2018 | - | -$2.24 M(-1.5%) | -$11.13 M(+4.8%) |
| Mar 2018 | - | -$2.27 M(-12.8%) | -$10.61 M(-8.9%) |
| Dec 2017 | -$11.67 M(+74.7%) | -$2.60 M(-35.1%) | -$11.65 M(+27.3%) |
| Sept 2017 | - | -$4.01 M(+132.6%) | -$9.15 M(+40.8%) |
| June 2017 | - | -$1.73 M(-47.9%) | -$6.50 M(-16.3%) |
| Mar 2017 | - | -$3.31 M(+3112.6%) | -$7.77 M(+16.0%) |
| Dec 2016 | -$6.68 M(-63.2%) | -$103.00 K(-92.4%) | -$6.70 M(-22.4%) |
| Sept 2016 | - | -$1.36 M(-54.5%) | -$8.62 M(-28.3%) |
| June 2016 | - | -$3.00 M(+34.0%) | -$12.03 M(-14.7%) |
| Mar 2016 | - | -$2.23 M(+10.0%) | -$14.11 M(-22.2%) |
| Dec 2015 | -$18.13 M(-18.1%) | -$2.03 M(-57.4%) | -$18.13 M(-45.5%) |
| Sept 2015 | - | -$4.77 M(-6.1%) | -$33.27 M(+5.3%) |
| June 2015 | - | -$5.08 M(-18.9%) | -$31.59 M(+25.2%) |
| Mar 2015 | - | -$6.25 M(-63.6%) | -$25.24 M(+14.0%) |
| Dec 2014 | -$22.14 M(+46.2%) | -$17.17 M(+456.0%) | -$22.14 M(+240.8%) |
| Sept 2014 | - | -$3.09 M(-342.4%) | -$6.50 M(+1.0%) |
| June 2014 | - | $1.27 M(-140.4%) | -$6.43 M(-44.5%) |
| Mar 2014 | - | -$3.15 M(+106.7%) | -$11.58 M(-23.5%) |
| Dec 2013 | -$15.14 M(-39.0%) | -$1.53 M(-49.6%) | -$15.14 M(-46.6%) |
| Sept 2013 | - | -$3.02 M(-21.9%) | -$28.36 M(+3.0%) |
| June 2013 | - | -$3.87 M(-42.4%) | -$27.55 M(-1.3%) |
| Mar 2013 | - | -$6.72 M(-54.4%) | -$27.93 M(+12.6%) |
| Dec 2012 | -$24.84 M(+39.0%) | -$14.75 M(+567.3%) | -$24.80 M(+71.8%) |
| Sept 2012 | - | -$2.21 M(-48.0%) | -$14.43 M(-0.1%) |
| June 2012 | - | -$4.25 M(+18.2%) | -$14.45 M(-19.9%) |
| Mar 2012 | - | -$3.60 M(-17.9%) | -$18.03 M(+1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$17.86 M(-13.7%) | -$4.38 M(+96.5%) | -$17.86 M(-32.9%) |
| Sept 2011 | - | -$2.23 M(-71.5%) | -$26.62 M(-1.2%) |
| June 2011 | - | -$7.83 M(+128.6%) | -$26.95 M(+23.7%) |
| Mar 2011 | - | -$3.42 M(-73.9%) | -$21.79 M(+5.7%) |
| Dec 2010 | -$20.69 M(+446.6%) | -$13.14 M(+415.4%) | -$20.62 M(+110.2%) |
| Sept 2010 | - | -$2.55 M(-4.5%) | -$9.81 M(+20.0%) |
| June 2010 | - | -$2.67 M(+18.2%) | -$8.18 M(+20.0%) |
| Mar 2010 | - | -$2.26 M(-3.3%) | -$6.82 M(+80.1%) |
| Dec 2009 | -$3.78 M(-25.8%) | -$2.33 M(+155.3%) | -$3.78 M(+262.4%) |
| Sept 2009 | - | -$914.40 K(-30.1%) | -$1.04 M(-65.5%) |
| June 2009 | - | -$1.31 M(-269.2%) | -$3.03 M(+7.8%) |
| Mar 2009 | - | $773.30 K(+90.7%) | -$2.81 M(-45.0%) |
| Dec 2008 | -$5.10 M(-45.6%) | $405.60 K(-114.0%) | -$5.10 M(-42.6%) |
| Sept 2008 | - | -$2.90 M(+165.7%) | -$8.89 M(+11.1%) |
| June 2008 | - | -$1.09 M(-28.3%) | -$8.00 M(-10.0%) |
| Mar 2008 | - | -$1.52 M(-55.0%) | -$8.88 M(-5.4%) |
| Dec 2007 | -$9.39 M(+2.8%) | -$3.38 M(+68.3%) | -$9.39 M(+8.4%) |
| Sept 2007 | - | -$2.01 M(+1.7%) | -$8.66 M(+0.5%) |
| June 2007 | - | -$1.98 M(-2.4%) | -$8.61 M(+4.2%) |
| Mar 2007 | - | -$2.02 M(-23.6%) | -$8.27 M(-9.4%) |
| Dec 2006 | -$9.13 M(-41.9%) | -$2.65 M(+34.7%) | -$9.13 M(-10.1%) |
| Sept 2006 | - | -$1.97 M(+20.7%) | -$10.16 M(-10.3%) |
| June 2006 | - | -$1.63 M(-43.6%) | -$11.32 M(-19.2%) |
| Mar 2006 | - | -$2.89 M(-21.5%) | -$14.02 M(-10.7%) |
| Dec 2005 | -$15.70 M(-9.3%) | -$3.68 M(+17.3%) | -$15.70 M(-6.3%) |
| Sept 2005 | - | -$3.13 M(-27.5%) | -$16.76 M(-8.2%) |
| June 2005 | - | -$4.33 M(-5.2%) | -$18.26 M(+1.6%) |
| Mar 2005 | - | -$4.56 M(-3.6%) | -$17.98 M(+3.9%) |
| Dec 2004 | -$17.30 M(+21.6%) | -$4.74 M(+2.3%) | -$17.30 M(-0.8%) |
| Sept 2004 | - | -$4.63 M(+14.5%) | -$17.45 M(+11.4%) |
| June 2004 | - | -$4.05 M(+4.0%) | -$15.66 M(+4.2%) |
| Mar 2004 | - | -$3.89 M(-20.3%) | -$15.03 M(+86.7%) |
| Dec 2003 | -$14.23 M(-48.4%) | -$4.88 M(+71.3%) | -$8.05 M(-29.6%) |
| Sept 2003 | - | -$2.85 M(-16.6%) | -$11.43 M(-25.4%) |
| June 2003 | - | -$3.41 M(-210.5%) | -$15.32 M(-18.6%) |
| Mar 2003 | - | $3.09 M(-137.4%) | -$18.83 M(-31.7%) |
| Dec 2002 | -$27.56 M(+60.2%) | -$8.26 M(+22.4%) | -$27.56 M(+8.6%) |
| Sept 2002 | - | -$6.74 M(-2.6%) | -$25.37 M(+13.7%) |
| June 2002 | - | -$6.92 M(+22.8%) | -$22.30 M(+16.2%) |
| Mar 2002 | - | -$5.64 M(-7.0%) | -$19.19 M(+11.6%) |
| Dec 2001 | -$17.20 M(+70.3%) | -$6.06 M(+64.8%) | -$17.20 M(+15.6%) |
| Sept 2001 | - | -$3.68 M(-3.5%) | -$14.88 M(+9.9%) |
| June 2001 | - | -$3.81 M(+4.5%) | -$13.54 M(+9.7%) |
| Mar 2001 | - | -$3.65 M(-2.4%) | -$12.34 M(+22.2%) |
| Dec 2000 | -$10.10 M(+148.9%) | -$3.74 M(+59.6%) | -$10.10 M(+58.7%) |
| Sept 2000 | - | -$2.34 M(-10.5%) | -$6.36 M(+58.2%) |
| June 2000 | - | -$2.62 M(+86.0%) | -$4.02 M(+186.0%) |
| Mar 2000 | - | -$1.41 M | -$1.41 M |
| Dec 1999 | -$4.06 M(-171.1%) | - | - |
| Dec 1998 | $5.71 M(-248.4%) | - | - |
| Dec 1997 | -$3.85 M | - | - |
FAQ
- What is Seelos Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Seelos Therapeutics?
- What is Seelos Therapeutics annual EBIT year-on-year change?
- What is Seelos Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Seelos Therapeutics?
- What is Seelos Therapeutics quarterly EBIT year-on-year change?
- What is Seelos Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Seelos Therapeutics?
- What is Seelos Therapeutics TTM EBIT year-on-year change?
What is Seelos Therapeutics annual earnings before interest & taxes?
The current annual EBIT of SEEL is -$37.81 M
What is the all time high annual EBIT for Seelos Therapeutics?
Seelos Therapeutics all-time high annual earnings before interest & taxes is $6.05 M
What is Seelos Therapeutics annual EBIT year-on-year change?
Over the past year, SEEL annual earnings before interest & taxes has changed by +$35.71 M (+48.58%)
What is Seelos Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of SEEL is $1.73 M
What is the all time high quarterly EBIT for Seelos Therapeutics?
Seelos Therapeutics all-time high quarterly earnings before interest & taxes is $10.54 M
What is Seelos Therapeutics quarterly EBIT year-on-year change?
Over the past year, SEEL quarterly earnings before interest & taxes has changed by -$8.81 M (-83.56%)
What is Seelos Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of SEEL is $4.20 M
What is the all time high TTM EBIT for Seelos Therapeutics?
Seelos Therapeutics all-time high TTM earnings before interest & taxes is $4.20 M
What is Seelos Therapeutics TTM EBIT year-on-year change?
Over the past year, SEEL TTM earnings before interest & taxes has changed by +$55.23 M (+108.23%)